Clinical Trial Update: Acute Bronchiolitis and Severity Markers: Interest in Protein CC16 [NA]

View source ↗

Summary

This clinical trial update discusses interest in using CC16 as a severity biomarker for acute bronchiolitis, with no results or phase details provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Acute Bronchiolitis | NA | Status: UNKNOWN